R&D | January 06, 2026
Insilico Medicine teams up with Servier to fast-track AI-driven cancer drugs
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
Under the agreement, Insilico could receive up to $32 million in upfront and near-term R&D payments
India plays a critical role in Bristol Myers Squibb’s global strategy
Terray and BMS aim to accelerate small molecule drug discovery by harnessing EMMI’s integrated experimental and AI capabilities
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
Currently focused on platform-related queries, elva.AI is the first step in ekincare’s broader roadmap
This collaboration marks a significant milestone for Abluva as the company aims to deliver value and innovative solutions in agentic AI security
To streamline complex medical writing workflows with GenAI
QuantumNexis will serve as the innovative engine for HCTI's recurring revenue business lines
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
This innovative platform is strategically essential to developing and scaling high-value life sciences use cases such as streamlining the content supply chain
Subscribe To Our Newsletter & Stay Updated
